WallStreetZen

NASDAQ: VXRT
Vaxart Inc Earnings & Revenue

VXRT past revenue growth

How has VXRT's revenue growth performed historically?
Company
-77.57%
Industry
606.32%
Market
28.71%
VXRT's revenue has grown slower (-33.62% per year) than the US Biotechnology industry average (120.44%)
Performance
VXRT's revenue has grown slower (-33.62% per year) than the US market average (16.77%)
Performance
VXRT's revenue growth is slowing down - its growth over the last year (-77.57%) is below its 5-year compound annual rate (-33.62%)
Performance

VXRT earnings and revenue history

Current Revenue
$1.7M
Current Earnings
-$46.9M
Current Profit Margin
-2,844.2%

VXRT Return on equity

Current Company
-39.8%
Current Industry
-34.6%
Current Market
31.1%
VXRT's Return on Equity (-39.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

VXRT Return on assets

Current Company
-32.5%
Current Industry
-9.2%
Current Market
6.5%
VXRT is generating lower Return on Assets (-32.5%) than the US Biotechnology industry average (-8.58%)
Performance

VXRT Return on capital employed

Current Company
-24.1%
Current Industry
4.4%
VXRT's ability to generate Return on Capital (-24.1%) has decreased compared to 3 years ago (-3.52%)
Performance

VXRT earnings dates

Next earnings date
Aug 4, 2021

Vaxart Earnings & Revenue FAQ

What were VXRT's earnings last quarter?

Vaxart (NASDAQ: VXRT) reported Q1 2021 earnings per share (EPS) of -$0.14, up 600% year over year. Total Vaxart earnings for the quarter were -$16.01 million. In the same quarter last year, Vaxart's earnings per share (EPS) was -$0.02.

What was VXRT's earnings growth in the past year?

As of Q2 2021, Vaxart's earnings has grown null year over year. Vaxart's earnings in the past year totalled -$46.93 million.

What is VXRT's earnings date?

Vaxart's earnings date is Aug 04, 2021. Add VXRT to your watchlist to be reminded of VXRT's next earnings announcement.

What was VXRT's revenue last quarter?

Vaxart (NASDAQ: VXRT) reported Q1 2021 revenue of $506.00 thousand up 82.56% year over year. In the same quarter last year, Vaxart's revenue was $2.90 million.

What was VXRT's revenue growth in the past year?

As of Q2 2021, Vaxart's revenue has grown -77.57% year over year. This is 683.9 percentage points lower than the US Biotechnology industry revenue growth rate of 606.32%. Vaxart's revenue in the past year totalled $1.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.